Results 241 to 250 of about 178,982 (291)

[Kanamycin].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1978
openaire   +1 more source

Comparative Ototoxicity of Kanamycin a and Kanamycin B in the Guinea Pig

Acta Oto-Laryngologica, 1987
It has previously been shown that simple compounds with multiple amine groups are ototoxic, the degree of ototoxicity depending on the number of amine groups in the molecule. The relationship between the number of amino groups and ototoxicity in aminoglycoside was studied using kanamycin A and kanamycin B, which contain 4 and 5 amino groups ...
M W Yung
exaly   +3 more sources

Determination of Kanamycin by High Performance Liquid Chromatography

open access: yesMolecules, 2019
Kanamycin is an aminoglycoside antibiotic widely used in treating animal diseases caused by Gram-negative and Gram-positive infections. Kanamycin has a relatively narrow therapeutic index, and can accumulate in the human body through the food chain.
Qinghua Wu, Hualin Yang
exaly   +2 more sources

Kanamycin resistance during in vitro development of pollen from transgenic tomato plants [PDF]

open access: yesPlant Cell Reports, 1987
Effects of kanamycin on pollen germination and tube growth of pollen from non-transformed plants and from transgenic tomato plants containing a chimaeric kanamycin resistance gene were determined. Germination of pollen was not affected by the addition of
R J Bino, J Hille
exaly   +3 more sources

Clinical Experiences with Kanamycin

New England Journal of Medicine, 1958
THIS report describes our experience with kanamycin§ in the treatment of 25 severe and acute infections in the adult. In general, the new antimicrobial agent has been administered for two kinds of infections—those caused by penicillin-resistant staphylococci and those resulting from invasion by a number of common gram-negative bacilli.
P A, BUNN, A, BALTCH, O, KRAJNYAK
openaire   +3 more sources

Kanamycin

Drug and Therapeutics Bulletin, 1963
Kanamycin sulphate (Kannasyn - Bayer) was introduced in Britain in 1959 mainly for use against resistant staphylococci. More recently the manufacturers have re-assessed the drug, and they now advocate it only for infections caused by Gram-negative organisms.
openaire   +1 more source

Kanamycin

Archives of Internal Medicine, 1959
George M. Eisenberg   +2 more
  +5 more sources

Home - About - Disclaimer - Privacy